Journals in Clinical virology

1-10 of 11 results in All results

Antiviral Research

• ISSN: 0166-3542
• 5 Year impact factor: 5
• Impact factor: 4.5

Antiviral Research aims to publish manuscripts in the field of prevention and treatment of viral diseases in humans and vertebrate animals, and encourages authors to the submit manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases. The journal is an Official Publication of the International Society for Antiviral Research. The types of papers published in Antiviral Research includes original research reports, short communications, commentaries and invited review* articles on the control of viral infections in humans. The journal’s scope encompasses:antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action.identification and validation of new drug targets;laboratory animal models of viral diseases for antiviral efficacy testing;evolution of drug-resistant viruses and the development of effective counter measures;pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses;assessments of drug safety;new or improved vaccines against viral infections of humans; the prevention and treatment of viral diseases of vertebrate animals, and reports of the testing of veterinary vaccines in the target animal species. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis that must be clearly described in the manuscript.Antiviral Research journal does not publish reports on viral diseases of plants or of insects, crustaceans or other invertebrates. Studies of viral diseases of livestock and companion animals must be clearly related to the development of realistic therapies. Papers on veterinary vaccines should report findings in the target animal species.We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We discourage the submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays. Citations of reports that have not undergone peer review must include the note "[not peer-reviewed]."ISAR members Authors who are ISAR members are encouraged to contact ISAR after their paper has been accepted for publication in order to benefit from their published work being highlighted in ISAR postings on their social media platforms (further details on this will be given in the AVR acceptance letter). *Antiviral Research journal has started a new initiative to publish at least two thematic special issues per year, containing invited reviews in addition to the ad hoc invitations to experts in the areas within the scope of the journal.

Subscribe

Clinical Microbiology Newsletter

• ISSN: 0196-4399

Clinical Microbiology Newsletter is published bi-monthly to to provide consistent educational features and to keep pace with advances in the fast-moving field of Clinical Microbiology.Clinical Microbiology Newsletter aims to provide articles to enable you to streamline procedures and improve results. It publishes reviews on infectious disease pathogens, reports on changes that affect your work, including articles on new diagnostic techniques, regulatory and guideline changes, and challenging diagnostic dogmas, clinical cases focused on diagnostic approaches for both common and uncommon pathogens.The journal publishes three types of articles:Mini-reviews Case presentationsMicrobe SnapshotsThese articles cover topics including:Minireviews on the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of infectious diseases,Practical articles on common and contemporary laboratory techniques,Indispensable updates on important clinical problems that impact the clinical laboratory,Editorials and opinions on controversial issues in laboratory medicine,Case-based articles focused on diagnostic approaches for infectious pathogens,Snapshots highlighting specific infectious pathogens,Helpful tips on improving the laboratory workplace.

Subscribe

Clinical Microbiology and Infection

• ISSN: 1198-743X
• 5 Year impact factor: 9.3
• Impact factor: 10.9

Clinical Microbiology and Infection (CMI) is a monthly publication in English of the European Society of Clinical Microbiology and Infectious Diseases and publishes peer-reviewed papers that present basic and applied research relevant to therapy and diagnostics in the fields of microbiology, infectious diseases, virology, parasitology, immunology and epidemiology as related to these fields.

Subscribe

Diagnostic Microbiology and Infectious Disease

• ISSN: 0732-8893
• 5 Year impact factor: 2
• Impact factor: 2.1

Diagnostic Microbiology and Infectious Disease provides up to date and extensive articles on clinical microbiology.Diagnostic Microbiology and Infectious Disease aims to publish latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. It publishes articles on studies in bacteriology, immunology, immunoserology.Submissions on new procedures, unusual cases, controversial issues, and important new literature. are particularly welcomed.The journal publishes topics including:Informed commentaries on new antibioticsRapid and cost-effective methods in the laboratoryInstructive case studies with emphasis on complex circumstancesInsightful editorials on important current issuesBook reviews that keep you up-to-date on recently published literatureLaboratory and clinical management of microbial diseasesEpidemiology and pathogenesis of infectionsAutomation in the diagnostic microbiology laboratoryAntibiotic susceptibility testing

Subscribe

Indian Journal of Medical Microbiology

• ISSN: 0255-0857
• 5 Year impact factor: 1.4
• Impact factor: 1.4

An official journal of the Indian Association of Medical MicrobiologistsIndian Journal of Medical Microbiology (IJMM) provides comprehensive coverage of medical microbiology, as well as infectious diseases. We welcome wide ranging contributions; from basic research at laboratory to clinical trials, including bacteriology, mycobacteriology, virology, mycology and parasitology, infection prevention and control, and infectious diseases.We publish articles under the following subject categories:Antimicrobial susceptibility and antimicrobial stewardship: surveillance of antimicrobial susceptibility in bacteria, viruses, fungi and parasites of importance in humans, animals, and the environment that are frequently interconnected; mechanisms of action, resistance and interactions. The role of antimicrobial stewardship programs in hospitals and its effectiveness.Clinical microbiology: understanding pathogenesis, virulence factors of the diseases caused by bacteria, viruses, mycobacteria, parasites and fungi in humans, clinical presentation, newer methods and tools for diagnosis of disease and therapeutic options; community health with respect to infection burden and prevention, disease epidemiology and climate change.Emerging infectious diseases: understanding the epidemiology of new and emerging infections or old infections having a resurgence in humans including zoonosis; their pathophysiology, clinical presentation, diagnosis and treatment.Medical mycology and mycobacteriology: pathogenesis, diagnosis, drug susceptibility, therapy, clinical immunology, autoimmune diseases, and immune responses to infections, vaccine development, epidemiology, public health and outbreak investigation of diseases in humans.Hospital infection: various hospital associated infections -their analysis, control, prevention and lessons learnt, newer methodologies to track HAI's, hospital outbreaks.Molecular studies: application of phenotypic, genotypic and molecular techniques in the study of virulence, AMR genes, epidemiology, outbreak investigations and public health.Microbiome and microbial ecology in health: the normal microbiome and dysbiosis; structure of microbial ecosystems and communities; microbial ecology, with an emphasis on how microorganisms interact with their environment, their host and each other and their impact on general health and treatment of disease. the normal microbiome and dysbiosis and its association with disease conditions; and microbial ecosystems and communities.Immunology: Clinical immunology, autoimmune diseases, and immune responses to infectionsVaccinology and therapeutics: research in identifying vaccine targets, novel drug discovery and therapeutics.IJMM publishes article types such as original research, review articles, systematic reviews, meta-analysis, clinical trials, correspondence, case reports and a new section - infectious disease grand rounds.High quality scientific content related to infections from dental and veterinary sciences (like zoonotic illnesses) can also be submitted.

Subscribe

Journal of Clinical Virology

• ISSN: 1386-6532
• 5 Year impact factor: 4
• Impact factor: 4

Journal of Clinical Virology is an international journal and is the Official journal of the Pan American Society for Clinical Virology and The European Society for Clinical Virology.Journal of Clinical Virology aims to publish papers and reviews on the clinical aspects of human virology. It publishes articles on diagnostical methods and virus-induced clinical conditions. The manuscripts should be clinically practical and relevant.Submissions on new technologies for viral diagnosis and monitoring are particularly welcomed.The journal publishes on topics that include:• new diagnostic technologies • nucleic acid amplification and serologic testing • targeted and metagenomic next-generation sequencing • emerging pandemic viral threats • respiratory viruses • transplant viruses • chronic viral infections • cancer-associated viruses • gastrointestinal viruses • central nervous system viruses • one health (excludes animal health)Journal of Clinical Virology does not accept submissions on single cases or case series. Please submit manuscripts of this type to IDcases. Journal of Clinical Virology also does not accept submissions on fundamental virology. Please submit manuscripts of this type to Virology.

Subscribe

Journal of Virological Methods

• ISSN: 0166-0934
• 5 Year impact factor: 2
• Impact factor: 2.2

Covering methodology and basic scienceThe Journal of Virological Methods focuses on original, high quality research papers that describe novel and comprehensively tested methods which enhance human, animal, plant, bacterial or environmental virology and prions research and discovery.The methods may include, but not limited to, the study of:Viral components and morphologyVirus isolation, propagation and development of viral vectorsViral pathogenesis, oncogenesis, vaccines and antiviralsVirus replication, host-pathogen interactions and responsesVirus transmission, prevention, control and treatmentViral metagenomics and viromeVirus ecology, adaption and evolutionApplied virology such as nanotechnologyViral diagnosis with novelty and comprehensive evaluationWe seek articles, systematic reviews, meta-analyses and laboratory protocols that include comprehensive technical details with statistical confirmations that provide validations against current best practice, international standards or quality assurance programs and which advance knowledge in virology leading to improved medical, veterinary or agricultural practices and management.

Subscribe

Microbes and Infection

• ISSN: 1286-4579
• 5 Year impact factor: 3
• Impact factor: 2.6

A Journal on Infectious Agents and Host Defenses A publication of the Institut PasteurThis journal has no page charges, publication is free of charge.Microbes and Infection publishes 8 peer-reviewed issues per year in all fields of infection and immunity, covering the different levels of host-microbe interactions, and in particular:the molecular biology and cell biology of the crosstalk between hosts (human and model organisms) and microbes (viruses, bacteria, parasites and fungi), including molecular virulence and evasion mechanisms.the immune response to infection, including pathogenesis and host susceptibility.emerging human infectious diseases.systems immunology.molecular epidemiology/genetics of host pathogen interactions.microbiota and host "interactions".vaccine development, including novel strategies and adjuvants.Clinical studies, accounts of clinical trials and biomarker studies in infectious diseases, unless purely descriptive, are within the scope of the journal.Microbes and Infection publishes articles on human pathogens or pathogens of model systems. However, articles on other microbes can be published if they contribute to our understanding of basic mechanisms of host-pathogen interactions. Purely descriptive and preliminary studies are discouraged.Reviews of a major topic of current interest must be commissioned by a Microbes and Infection editor. Unsolicited contributions and presubmission enquiries will not be considered.Special issues focus on the present knowledge of a virulent microbe and the disease it causes, the immune response in infectious disease, or on critical issues relevant to the scope of the journal.The journal is entering its 20th year of publication, and Essential Science IndicatorsSM (ESI) states that "Microbes and Infection has had a significant impact in the field of Immunology." https://www.editorialmanager.com/MICINF/default.aspxhttps://www.pasteur.fr/fr/ceris/publications-scientifiques/microbes-infectionThe full-text articles, etc, are available at:https://www.sciencedirect.com/journal/microbes-and-infection

Subscribe

Microbial Pathogenesis

• ISSN: 0882-4010
• 5 Year impact factor: 3.6
• Impact factor: 3.3

Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports.Research Areas Include:PathogenesisVirulence factorsHost susceptibility or resistanceImmune mechanismsIdentification, cloning and sequencing of relevant genesGenetic studiesViruses, prokaryotic organisms and protozoaMicrobiotaSystems biology related to infectious diseasesTargets for vaccine design (pre-clinical studies)The journal aims for rapid publication of articles of high quality and significance in an international forum. Please note that reviews are only accepted upon editorial invitation.Short Communications have the following limits. The manuscript should ideally contain no more than 4-6 Figures/Tables and 4000 words, including the title page, all sections of the manuscript (including the references), and Figure/Table legends. The abstract should be limited to 200 words.Microbial Pathogenesis does not accept submissions that primarily consist of (a) bioinformatics or computational analysis of public genomic or transcriptomic databases, or (b) the testing and evaluation of previously uncharacterized natural product-based drug candidates. The journal does not publish purely bioinformatic or computational studies without substantial experimental validation. Please be aware that experimental validation is a mandatory requirement for all submissions.

Subscribe

The Lancet

• ISSN: 0140-6736
• 5 Year impact factor: 106.9
• Impact factor: 98.4

The Lancet is an independent, international general medical journal founded in 1823 by Thomas Wakley. Since its first weekly issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people.The Lancet is committed to applying scientific knowledge to improve health and advance human progress. In our weekly issues, and Online First content, we publish some of the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health.

Subscribe